<unk>  has low acute toxicity in laboratory animals. It is rapidly hydrolyzed to benzoic acid and<unk>  alcohol.<unk>  alcohol is subsequently metabolized to benzoic acid. The conjugates of benzoic acid (hippuric acid and the glucuronide of benzoic acid) are rapidly eliminated in urine. When given in large doses to laboratory animals,<unk>  can cause hyperexcitation, loss of coordination, ataxia, convulsions, and respiratory paralysis.<unk>  can be a skin irritant when used as a topical scabicide. Overdose can result in blistering and hives or a rash can occur as an allergic reaction. As an excipient in some testosterone-replacement injectable medications,<unk>  has been reported as a cause of anaphylaxis in a case in Australia. Bayer includes this report in information for health professionals and recommends that physicians "should be aware of the potential for serious allergic reactions" to preparations of this type. In Australia, reports to ADRAC, which evaluates reports of adverse drug reactions for the Therapeutic Goods Administration, show several reports of allergic issues since the anaphylaxis case from 2011.
Benzyl benzoate
Olsalazine
Enarodustat
Ridinilazole
Ibotenic acid
Maralixibat chloride
Alpha-Hydroxyetizolam
Drupanol